Holding(s) In Company
Faron Pharmaceuticals Ltd has notified a change in its major holdings, with its voting rights falling to 9.37% from a previous 10.97%, totaling 21,342,679 voting rights. This change is attributed to an event altering the breakdown of voting rights and the amortization of the First and Second Tranche Bonds using treasury shares, as approved by share subscriptions.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | August 04, 2026 at 16:00:00 EEST |
TR-1: Standard form for notification of major holdings
- Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
| Non-UK issuer | X |
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments
| An event changing the breakdown of voting rights | X |
| Other (please specify) iii : Amortisation of the First and Second Tranche Bonds with treasury shares | X |
Details of person subject to the notification obligation iv
| Name | Faron Pharmaceuticals Ltd |
| City and country of registered office (if applicable) | Turku, Finland |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 3.8.2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 3.8.2026 |
- Total positions of person(s) subject to the notification obligation
| Resulting situation on the date on which threshold was crossed or reached | 9.37% | 9.37% | 21,342,679 |
| Position of previous notification (if applicable) | 10.97% | 10.97% | |
| A: Voting rights attached to shares | |||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | |
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) |
| FI4000153309 | 21,342,679 | 9.37% | |
| SUBTOTAL 8. A | 21,342,679 | 9.37% | |
B 1: Financial Instruments according to DTR5.3.1R (1) (a)
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
SUBTOTAL 8.B.2
| Faron Pharmaceuticals Ltd | 9.37% | 9.37% |
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
3.8.2026 Company announcement: Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First and Second Tranche Bonds
| Place of completion | Turku, Finland |
|---|---|
| Date of completion | 3.8.2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.